Scientists develop 'Holy Grail' weight loss jab that burns fat without affecting appetite or muscle mass
In a first round human trial slimmers in Sweden taking the new drug-currently known as ATR-258-found they burnt fat yet preserved muscle mass.
You are not logged in so some information on this page has been withheld. To see more, please log in.